TELUS Health and McGill University announce a multi-disciplinary million dollar research partnership

TELUS Health and McGill University announce a multi-disciplinary million 
dollar research partnership 
Health information technologies to improve care of patients with life-long 
chronic diseases 
MONTREAL, May 7, 2013 /CNW Telbec/ - TELUS Health and McGill University have 
entered into a three-year, million dollar partnership to create a learning 
environment and conduct research on how best to use technology to improve 
health and healthcare delivery for Canadians. This joint partnership with 
McGill is the second for TELUS Health, demonstrating once again that industry 
and academic communities can collaborate to produce independent, 
evidence-based research, in order to help address challenges that the Canadian 
healthcare system is facing. 
"This partnership will contribute to our effectiveness in generating 
quantifiable results by allowing us to document patient outcomes from our 
health IT applications and cutting-edge collaborative services," said Paul 
Lepage, President, TELUS Health. "It enables us to gain valuable knowledge and 
further insights on the impacts of ehealth initiatives from both the clinical 
and business perspectives on a national level." 
"We are delighted to create a multi-disciplinary partnership that promotes 
participation, collaboration and innovation, with the shared goal of 
translating advances in technology into transformative improvements in 
healthcare across Canada," said Professor Peter Todd, Dean of the Desautels 
Faculty of Management at McGill University. 
Putting patients at the centre of innovative and improved healthcare delivery 
Through this partnership, the first study receiving funds will focus on 
understanding how remote health monitoring integrated with a patient health 
portal can be used to improve the management of complex medical therapy for 
patients with chronic cardiovascular disease, which affects over three million 
Canadians. 
Widely used in chronic anticoagulant therapy for people living with 
cardiovascular disease, Warfarin requires close monitoring of patients, who 
currently must make regular visits to hospitals or clinics. This creates 
considerable inconvenience for patients, as well as being costly and 
inefficient. The research project, led by co-Principal Investigators Dr. 
Ariane Marelli of the Faculty of Medicine and Dr. Yeona Jang of the Desautels 
Faculty of Management, aims to help improve anticoagulation surveillance, 
while minimizing hospital visits and engaging the community with a 
patient-centred solution. 
"As our populations age and diseases become increasingly chronic and complex, 
the healthcare challenges we face are significant," said Dr. David Eidelman, 
McGill's Vice-Principal of Health Affairs and Dean of Medicine. 
"Collaborations like these are fundamental in harnessing the technology and 
research by outstanding scientists such as Drs. Jang and Marelli to provide 
the best care for the people in our communities. We are proud to be partnering 
with TELUS Health to accelerate these efforts." 
A year ago, TELUS Health announced a similar partnership with the University 
of Alberta, which focused on consumer health and personal health records. 
Other joint research projects, designed to support the TELUS provincial 
centres of excellence and diversity engagement, are expected to take place 
over the next three years. 
About McGill University and its Faculties of Management and Medicine 
Since 1821 McGill University in Montréal has been one of Canada's leading and 
most international post-secondary institutions. It is consistently ranked 
among the world's top research-intensive universities, with two campuses, 11 
faculties, 11 professional schools, 300 programs of study and some 38,000 
students from over 150 countries around the world. For over 100 years, the 
Desautels Faculty of Management at McGill has been recognized as one of the 
top international business schools in the world. The Desautels Faculty of 
Management emphasizes an integrated and holistic approach to the teaching, 
research and practice of management. Founded in 1829, the McGill Faculty of 
Medicine was the first faculty established at the University and the first 
medical faculty in Canada. Today, McGill is the leading medical research 
university nationally, and is renowned worldwide for its excellence in the 
health sciences. The McGill University Business Engagement Centre (MUBEC), 
which provides a single point of entry for companies seeking to partner with 
McGill, helped establish the new partnership with TELUS. More on McGill: 
www.mcgill.ca; more on McGill's Desautels Faculty of Management: 
www.mcgill.ca/desautels; more on McGill's Faculty of Medicine: 
www.mcgill.ca/medicine. 
About TELUS Health 
TELUS Health is a leader in telehomecare, electronic medical and health 
records, consumer health, benefits management and pharmacy management. TELUS 
Health solutions give health authorities, providers, physicians, patients and 
consumers the power to turn information into better health outcomes. For more 
information about TELUS Health, please visit telushealth.com. 
About TELUS 
TELUS (TSX: T, NYSE: TU) is a leading national telecommunications company in 
Canada, with $10.9 billion of annual revenue and more than 13.1 million 
customer connections, including 7.7 million wireless subscribers, 3.4 million 
wireline network access lines, 1.4 million Internet subscribers and 678,000 
TELUS TV customers. Led since 2000 by President and CEO, Darren Entwistle, 
TELUS provides a wide range of communications products and services, including 
wireless, data, Internet protocol (IP), voice, television, entertainment and 
video. 
In support of our philosophy to give where we live, TELUS, our team members 
and retirees have contributed more than $300 million to charitable and 
not-for-profit organizations and volunteered 4.8 million hours of service to 
local communities since 2000. Fourteen TELUS Community Boards lead local 
philanthropic initiatives. TELUS was honoured to be named the most outstanding 
philanthropic corporation globally for 2010 by the Association of Fundraising 
Professionals, becoming the first Canadian company to receive this prestigious 
international recognition. For more information about TELUS, please visit 
telus.com. 
Edelman Lauren Guay 514-315-1970 lauren.guay@edelman.com 
McGill University Media Relations Chris Chipello 514-398-4201 
christopher.chipello@mcgill.ca  TELUS Media Relations Jacinthe Beaulieu 
418-318-6102 jacinthe.beaulieu@telus.com 
McGill University Media Relations Leilani Ku 514-398-7131 
leilani.ku@mcgill.ca  
SOURCE: TELUS Corporation 
To view this news release in HTML formatting, please use the following URL: 
http://www.newswire.ca/en/releases/archive/May2013/07/c4168.html 
CO: McGill University
ST: Quebec
NI: TLS EDU HEA  
-0- May/07/2013 10:00 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.